QC Associate I, QCA (Cell and Molecular Biology)
Description
Our Culture
BioMarin’s Technical Operations group is responsible for creating our drugs for use in clinical trials and for scaling production of those drugs for the commercial market. These engineers, technicians, scientists and support staff build and maintain BioMarin’s cutting-edge manufacturing processes and sites, provide quality assurance and quality control to ensure we meet regulatory standards, and procure the needed goods and services to support manufacturing and coordinating the worldwide movement of our drugs to patients.
- Adhere and follow cGMPs guidelines and procedures. Escalate non-compliance concerns to management.
- Lead efforts to compliantly perform laboratory testing of in-process samples, finished product, non-routine samples, packaging and stability, etc.
- Become Subject Matter Expert in analytical methods incl: HPLC/UPLC, SDS Gels, UV Spectrophotometry, plate-based assays including ELISAs and cell-based Bioassays, PCR, etc.
- Provide technical expertise for analytical methods in QC, support the maintenance of method, and analytical equipment performance
- Analyze, trend, and review quality control non-routine, release, and stability testing data
- Experimental design, execution, and report writing—often for direct submission to pharmaceutical regulatory agencies
- Develop, optimize, validate and troubleshoot analytical test methods
- Draft and revise QC SOPs; contributes to data review and approval of results.
- Initiate and/or act as investigator/owner for laboratory investigations, deviations, and related corrective and preventative actions. Complete records in timely manner.
- May have one or more direct reports and is expected to provide technical and cGMP knowledge and guidance to the entire team
- Maintain the laboratory in an inspection-ready state including support of equipment management
- Interact directly with regulatory agency inspectors during audits
- Interface with other BioMarin departments (Manufacturing, Quality Assurance, Facilities, etc.) and contractors as necessary
- Support or lead continuous improvement in quality systems (procedures and systems) to improve organizational effectiveness, quality assurance compliance, and regulatory and other requirements (cGMP, ICH).
- Interpret and apply 21CFR, USP, EP, JP and ICH regulatory guidelines and directives
- Other duties as assigned
- 5-7 years of experience, preferably in a GMP environment.
- Cell based experience required. Cell-based work in gene therapy a plus.
- HPLC/UPLC, SDS Gels, UV Spectrophotometry, plate-based assays including ELISAs and cell-based Bioassays, PCR experience a plus
- Experience reviewing and executing on study protocols, participating in method optimization, transfer and validation studies a plus.
- Experience with working with mammalian cell cultures is not required but is highly preferred.
- 4-year science degree in Biology, Molecular Biology, Analytical Chemistry, Biochemistry, or similar disciplines is required.
Equal Opportunity Employer/Veterans/Disabled
An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
Who We Are
BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health.
Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities.
Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options.